China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC - Get Free Report)'s stock price was down 1.3% on Tuesday . The stock traded as low as $1.50 and last traded at $1.54. Approximately 84,835 shares traded hands during trading, an increase of 30% from the average daily volume of 65,272 shares. The stock had previously closed at $1.56.
China SXT Pharmaceuticals Trading Up 9.0%
The company has a fifty day moving average of $1.70 and a two-hundred day moving average of $2.45.
China SXT Pharmaceuticals Company Profile
(
Get Free Report)
China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Recommended Stories
Before you consider China SXT Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and China SXT Pharmaceuticals wasn't on the list.
While China SXT Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.